Login / Signup

Antitumoral Agent-Induced Constipation: A Systematic Review.

Agnès Calsina-BernaJesús González-BarboteoSilvia Llorens-TorroméJoaquim Julià-Torras
Published in: Cancers (2023)
The prevalence of constipation in patients undergoing antitumoral treatment is very diverse. Studies specifically designed to report the prevalence of antineoplastic treatment-induced constipation are needed. The importance of enteric neuronal integrity in gastrointestinal function was described. Thus, neuroprotection could be an area of research for the treatment of chemotherapy-induced gastrointestinal disorders.
Keyphrases
  • patients undergoing
  • risk factors
  • high glucose
  • diabetic rats
  • oxidative stress
  • stress induced